Skip to main content

EHAB Vission

EHAB’s Vision is to strengthen the European landscape in Advanced Therapies and Biomaterials (AT&B) by building a European interconnected value chain and powerhouse to making cell and tissue related therapies available to all European citizens, seizing opportunities in key parts of the AT&B value chain, consolidating EU assets, notably SMEs and increasing its international competitiveness. 

EHAB Mission

EHAB’s mission is to identify regional strengths, weaknesses, gaps and needs in a consolidated transregional AT&B value chain and to elaborate a joint action plan to strengthen the performance and capacity of the innovation ecosystems of e.g. SME’s innovation stakeholders and their efficient interconnection and their alignment towards EU-level priorities, jointly tackling challenges at EU, national, regional, and local level together with all the quadruple helix stakeholders.

Project members

EHAB is supported by various organisations at both regional and European levels, including: the Province of North Brabant, the Province of Limburg, the RegMed XB consortium, the Department of Economy, Science and Innovation of the Flemish Government, the Smart Health Pilot of the Vanguard Initiative, the Department of Health of the Government of Catalonia, Leitat, ASEBIO, the Vall d’Hebron Institute of Oncology, the Fraunhofer Institute for Manufacturing Engineering and Automation (Fraunhofer IPA), and the Marshal's Office of the Silesian Voivodeship.

Supported by:

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission as the granting authority. Neither the European Union nor the granting authority can be held responsible for them.”

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.